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Abstract 
Background: 
Cardiac allograph vasculopathy (CAV) is a multifactorial disease process that occurs in heart transplant 
(HTx) patients and has both immunologic and nonimmunologic components. Exercise has been proven to 
reduce the progression of CAV. The extent to which high intensity interval training (HIIT) can be utilized 
and its efficacy for delaying CAV is still being researched. 
Methods: 
A thorough search was conducted on three different databases including: MEDLINE-Ovid, Web of Science, 
and CINAHL. The keywords used during the search were “heart transplantation” and “high intensity 
interval training.” The search was narrowed to include only articles written in the past 5 years and articles 
published in the English language. The quality of evidence was assessed using GRADE. 
Results: 
Two articles were found that met inclusion criteria. The studies differed from each other in what was 
considered the control group. The Dal et al studycompared HIIT training to moderate exercise in a cross 
over trial with a 5-month washout period. Throughout the study endothelial wall damage was recorded. In 
the Nytrøen et al study participants were placed into a control or HIIT group. The HIIT group received HIIT 
therapy while the control was instructed to not modify their workouts for the duration of the study. At the 
end of the study endothelial wall measurements were measured via arterial ultrasound. 
Conclusion: 
These studies showed that HIIT therapy can delay the onset of CAV; however, due to the inadequacy of 
one of the studies it could not be determined if HIIT was better than continuous moderate exercise 
(CME). The Dall et al group did not have the sensitivity needed in their measurements of the endothelial 
wall damage to determine if it was more effective than CME. To determine the possible benefits of HIIT 
more research needs to be conducted. Since CAV is such a risk to HTx patients the optimal exercise 
program to delay CAV is of critical importance. 
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Abstract   
 
Background:  
Cardiac allograph vasculopathy (CAV) is a multifactorial disease process that occurs in 
heart transplant (HTx) patients and has both immunologic and nonimmunologic 
components.  Exercise has been proven to reduce the progression of CAV. The extent to which 
high intensity interval training (HIIT) can be utilized and its efficacy for delaying CAV is still 
being researched.   
Methods:   
A thorough search was conducted on three different databases including: MEDLINE-
Ovid, Web of Science, and CINAHL. The keywords used during the search were “heart 
transplantation” and “high intensity interval training.” The search was narrowed to include only 
articles written in the past 5 years and articles published in the English language. The quality of 
evidence was assessed using GRADE. 
Results:   
 Two articles were found that met inclusion criteria. The studies differed from each other 
in what was considered the control group. The Dal et al study compared HIIT training to 
moderate exercise in a cross over trial with a 5-month washout period. Throughout the study 
endothelial wall damage was recorded. In the Nytrøen et al study participants were placed into a 
control or HIIT group. The HIIT group received HIIT therapy while the control was instructed to 
not modify their workouts for the duration of the study. At the end of the study endothelial wall 
measurements were measured via arterial ultrasound.  
Conclusion:   
 These studies showed that HIIT therapy can delay the onset of CAV; however, due to the 
inadequacy of one of the studies it could not be determined if HIIT was better than continuous 
moderate exercise (CME). The Dall et al group did not have the sensitivity needed in their 
measurements of the endothelial wall damage to determine if it was more effective than CME. 
To determine the possible benefits of HIIT more research needs to be conducted. Since CAV is 
such a risk to HTx patients the optimal exercise program to delay CAV is of critical importance.  
 
Keywords: High intensity interval training, heart transplant, cardiac allograft vasculopathy 
 
 
 
 
 
 
 
 
 
 
 
4 
 
Acknowledgements 
 To our parents: Thank you for all of your support throughout all of our academic 
careers. We love you and appreciate all you have done for us. 
 
 To our classmates, loved ones, and friends: Thank you for your support through 
these crazy years. We needed the support and the encouragement you shared with us, 
thank you for being there when we needed you.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 
 
Table of Contents 
 
Biography.…..….…………….………………………………………………………………...….2 
Abstract.….……..…………..…………………………………………………………..................3 
Aknowledgments………………………………………………………………………………….4 
Table of Contents …...……………..………………………………………………………….......5 
List of Tables …...…….…………….…………………………………………………….............6 
List of Abbreviations.……....…………….…………………………………………….................6 
Background……………………………….………………………………………………….........7  
Methods……………..………………………..……………………………………………...…….9 
Results.….………………..……………………………..………………………………...…….…9 
Discussion………………………..……....…………………………………………………..…..13 
Conclusion…………………………………………………………………………………..…...15 
References...……………...……………………………………………………………................16 
Table 1……....…….……………………………………………………………………..…........19 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 
 
List of Tables: 
Table 1. Quality Assessment of Reviewed Articles 
 
 
List of Abbreviations 
 
CAV  Coronary Artery Vasculopathy 
CME  Continued Moderate Exercise  
FMD  Flow-mediated dilation 
HIIT  High-Intensity Interval Training 
HTx  Heart Transplant 
PAT  Pulse Amplitude Tomography  
RHI  Reactive Hyperemia Index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7 
 
The Effect of High Intensity Interval Training on Cardiac 
Allograft Vasculopathy 
BACKGROUND 
Heart transplant (HTx) recipients face a host of challenges after their operation ranging 
from, but not limited to, rejection, infection, malignancy, and vascular disease. One of the most 
prominent and fatal of these challenges is a coronary vascular complication known as coronary 
artery vasculopathy (CAV). CAV is seen in more than 50 percent of heart transplant patients in 
the first several years following the procedure1 and is one of the leading causes of morbidity and 
late mortality in heart transplantation patients.2 
The pathogenesis of CAV is a complex and a multifactorial process that has both 
immunologic and nonimmunologic components to it. The process begins with endothelial injury 
that leads to intimal thickening and eventual diffuse circumferential smooth muscle hyperplasia.3 
This initial injury can be caused by many things. We know the foreign vessels can initiate 
activation of both the humoral and cellular immune system, which results in progressive damage 
to the foreign coronary vessels.4 It seems that other important nonimmunologic factors have also 
been identified in playing a role in the development of the disease. Factors that have been linked 
to the development of CAV include: hyperlipidemia, hypertension, obesity, older age, 
cytomegalovirus infection, immunosuppressive drugs, and insulin resistance or poor glycemic 
control.3,5 To reduce morbidity and mortality in HTx patients the development and prevention of 
CAV must be explored. 
There are a few ways to observe the development of CAV. One such way would be to 
utilize intravascular ultrasonography to measure the change in intimal thickness within the 
coronary arteries.1 Another way would be to look at endothelial health, which can be an early 
indicator of the development of vessel damage.6,7 Endothelial health has been traditionally 
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measured using brachial flow-mediated dilation (FMD) measurements. A newer clinical tool to 
measure endothelial function is the digital pulse amplitude tonometry (PAT). The studies we 
reviewed in this review looked at either intimal thickness or endothelial health to gauge the 
extent of disease in follow up. 
The current standard to reduce the risk of developing CAV is to begin antiproliferative 
drugs and statins shortly after transplantation.8 In addition to drug therapy, it has been proposed 
that exercise, in those that are healthy enough to participate, could also be beneficial in reducing 
the risk of developing CAV. Exercise has been shown to be very beneficial in the treatment of 
patients with coronary vascular disease and in treating the risk factors associated with 
development of CAV including: hyperlipidemia, hypertension, obesity, and poor glycemic 
control.9-11 Recently, exercise and its effectiveness in reducing the risk of developing CAV has 
been a topic targeted by researchers.12,13  Currently the standard for prophylactic treatment of 
CAV includes an exercise regimen along with antiproliferative pharmacologic agents, and a 
modification of common risk factors like hypertension, hyperlipidemia, hyperglycemia, obesity, 
and smoking.3 But what type of exercise is most beneficial for this specific patient population is 
still largely unknown.   
Recent research shows that higher intensity exercise is superior to moderate continuous 
exercise in patients with coronary vascular disease and stable heart failure.14,15 Although some 
research has been done, the best type of exercise to prevent CAV in HTx patients has not been 
thoroughly examined. With recent research showing that high intensity interval training (HIIT) is 
well tolerated in HTx patients,12,13,16-19 this review looks at the research that has been done in 
regards of exercise intensity and the prevention of CAV in HTx patients. 
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METHODS 
A thorough search was conducted on three different databases including: MEDLINE-
Ovid, Web of Science, and CINAHL. The keywords used during the search were “heart 
transplantation” and “high intensity interval training.” The search was narrowed to include only 
articles written in the past 5 years and articles published in the English. Search results were then 
narrowed even further to include only articles that focused on vascular health as their major 
outcome. Works cited pages of included articles were then reviewed to include other possible 
relevant studies. After applying inclusion criteria to the database results, articles were then 
assessed for quality using the Grading of Recommendations, Assessment, Development, and 
Evaluation (GRADE).20 
RESULTS 
 The initial literature search yielded a total of 23 articles for review. After removal of 
duplicate papers and application of inclusion criteria, two articles were included. There were 
multiple researched papers produced from two data sets by two different research groups. One 
research group compared HIIT to continuous moderate exercise (CME)1while the other group 
compared HIIT to a control with no structured exercise regime just medication therapy.2 Only 
one article from each research group met inclusion criteria due to the other papers not focusing 
on vascular health as their main outcome measured. See Table 1. 
Nytrøen et al 
This study13 was published in 2013 and is a randomized clinical trial consisting of 43 post 
heart transplant patients. The study looked at the effectiveness of HIIT training vs a control 
group which received full medical care but no additional structured exercise regimen. There were 
two papers13, 16 produced from this same randomized clinical trial. The one included in this 
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analysis focused on the progression of CAV by monitoring patients’ coronary vessels via 
intravascular ultrasound. By using intravascular ultrasound, the team was able to evaluate 
percent atheroma volume, total atheroma volume, total plaque volume, and maximal intimal 
thickness to assess the health of the coronary vessels and progression of CAV over the year of 
the study.13 
For this study 192 potential participants were screened for eligibility. Of the 192 potential 
participants 57 met the study's inclusion criteria. The participant had to be over 18 years of age, 
1-8 years post-transplant, be in optimal medical treatment, be in a stable condition, be able to 
perform maximal exercise on a treadmill, and have a willingness to participate in a 1-year HIIT 
exercise program. Of the 57 that were initially recruited, 5 did not complete the trial. One 
withdrew from the study and the other 4 were, “excluded because of logistics.”13  
The 52 participants were then randomly assigned to 2 groups by a computer 
randomization sequence. The intervention group underwent 3 separate 8-week periods where 
they participated in supervised high intensity interval training 3 times a week. The HIIT program 
consisted of bouts of 4 minutes of exercise performed at or above 91.5 % of the patient’s 
maximal heart rate. In between the 8-week periods the HIIT group was encouraged to continue 
with exercise but there was no formal supervised training provided. Along with a formal exercise 
program the intervention group also received full medical therapy including immunosuppressive 
therapy and statins. The control group had no formal exercise training but received full medical 
therapy and exercise was encouraged in the group. In the 3 months leading up to follow up 
testing the control group reported that 33% had exercised once a week or less, 43% exercised 2-3 
times per week, and 24% had exercised 4 or more times a week.13 
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Both the HIIT group and control group had baseline testing done initially and again after 
1 year of treatment. Testing included intravascular ultrasound, peak flow VO2, and blood draws 
including a lipid panel, blood glucose testing, creatinine, CRP, and interleukin levels. The article 
that was included in this review focused on intravascular ultrasound results as a means to 
determine the progression of CAV in the 2 groups during the year of the study. The researchers 
had a blind technician perform the ultrasound and report the results. From the ultrasound results 
the researchers calculated change in percent atheroma volume, total atheroma volume, total 
plaque volume, and maximal intimal thickness.13 The other testing results mentioned above were 
discussed further in an earlier paper by the research group.16 
The HIIT group showed a statistically significant smaller increase in percent atheroma 
volume, total atheroma volume, and total plaque volume when compared to the control group. 
Percent atheroma volume increased by 0.9% {-0.3% to 1.9%} in the HIIT group while it 
increased by 2.5% {1.6% to 3.5%} in the control group (p = 0.021). Total atheroma increased by 
0.3% mm3/mm {0.0 to 0.6}in the HIIT group and increased by 1.1% mm3/mm {0.6% to 1.7%} 
in the control group (p = 0.054). Total plaque volume increased by 8.0 mm3 {0.3 to 15.7} in the 
HIIT group and increased by 25.6 mm3{14.8 to 36.4} in the control group (p = 0.011). It was 
also observed that maximal intimal thickness increased at a faster rate in the control group but 
the findings were not statistically significant. A qualitative analysis of the plaque was also done 
in the 2 groups but there was no significant difference between the groups.13 
Dall et al 
 This study12 was published in 2015 and is a randomized control crossover trial in HTx 
patients aimed at examining the difference between continued moderate exercise (CME) and 
HIIT. The outcomes of this study were published into multiple papers, the paper used in this 
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analysis focused on vascular function, biomarkers, and quality of life as primary 
outcomes.  Vascular health was assessed by the utilization of EndoPAT 2000. This device 
measures endothelial stiffness and function.12  
 Participants for the study were screened for eligibility and of the 20 patients screened, 17 
were deemed eligible. Exclusion criteria included HTx within a year, patients younger than 18 
years, and patients deemed unstable due to severe CAV, malignant disease, or multi-organ 
transplant. The participants also needed to be physically capable to perform the workouts. Of the 
17 participants that started the study 16 completed it.12  
 An independent researcher not involved with the investigation assisted in the envelope 
randomization of participants to the HIIT washout CME group or CME washout HIIT group.  
The workout regimens took place on ergometer bikes 3 times per week under supervision. Each 
HIIT session was 30 minutes long and consisted of 16 minutes of interval training, at 4-, 2-, and 
1-minute intervals of high intensity exercise (VO2 peak>80%) each of the intervals was 
separated by 2 minutes of moderate exercise at 60% VO2 peak. The CME sessions consisted of 
45 minutes of biking at 60% to 70% VO2 peak. All sessions, for both groups, began and ended 
with  10-minute warm up and cool down sessions. Each program, CME and HIIT, took place for 
12 weeks. Following the 12-week workout program participants went into a 5-month washout 
period where they were told to exercise as usual. Then participants returned to complete the other 
arm of the experiment for 12 more weeks of exercise.12  
The EndoPAT 2000, used to examine endothelial function, was used throughout the study 
to assess the vascular benefits of  HIIT and CME. Data points were collected at baseline and 
follow up of each exercise program. The measurement of endothelial function is described as the 
reactive hyperemia index (RHI). The noninvasive, operator independent EndoPAT 2000 
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evaluates the endothelial function by measuring a pulsatile volume change in the fingertip before 
and after the brachial artery is occluded. A baseline measurement is obtained and then a blood 
pressure cuff is used to occlude the artery for 5 minutes at a pressure >200 mm Hg.  After the 
cuff is released the EndoPAT 2000 reads the hyperemic response and the RHI is automatically 
calculated. The augmentation index (AI) is created in an analysis of the pulse wave data. The AI 
is correlated to an increase arterial stiffness. As AI increases so does arterial stiffness.12 
In the HIIT and CME branches of the study the RHI at baseline was 2.2. The follow up 
RHI for was 2.5 and 2.2, respectively. There was no significant statistical difference between 
groups.  Similarly there was no significant difference noted in arterial wall stiffness between the 
2 groups. The effect of the workout intervention was lost after the 5-month period of no exercise 
and then participants began the other workout regimen. The study went on to discuss other 
outcomes such as biomarkers and quality of life which were not outcomes in Nytrøen et al and 
are not compared in this analysis.12  
DISCUSSION 
  
 CAV is a progressive and detrimental disease that occurs in post heart transplant patients. 
It remains one of the major causes of death in the late post-transplant phase.2 To treat CAV a 
multidisciplinary approach needs to be implemented to adjust many aspects of a patient’s life. 
Although medication therapy with statins and anti-proliferative drugs have been shown to be 
effective in slowing progression of CAV, therapies used today are still imperfect and exercise is 
being evaluated as a therapy to further decrease the risk of developing CAV.12,16 According to 
the findings of the included studies,12,13 HIIT therapy can be an effective tool to slow the 
progression of CAV when used in conjunction with medical therapy. Although, more testing 
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needs to be done to determine how soon after transplant this therapy can be initiated or if it can 
be tolerated in individuals that are less than stable post-transplant. 
The study done by Nytrøen et al12 found that HIIT was significantly better at slowing the 
progression of CAV when compared to a control group only receiving medical therapy. This 
result proves that HIIT can be an effect therapy used to treat CAV. It is not surprising that 
exercise yielded slower CAV progression; as it is known, exercise is cardiovascularly protective 
and can decrease risk factors associated with the development of CAV.21 
        Nytrøen et al13 may have had some biases within the study protocol. Over 190 
participants were screened for this study and only 26 of those ended up participating in the HIIT 
program. The inclusion criteria were very strict and removed over two thirds of the participants 
that were screened initially. The study required that the patient be stable post-transplant and 
willing to participate in a yearlong HIIT program which removed a majority of the potential 
participants. This presents a possible selection bias. If the study only looked at stable patients 
then maybe these patients had a decreased risk of developing CAV just based on the fact that 
they were in better condition following their transplant procedure. This potential bias makes it 
difficult to assess whether or not HIIT could be an appropriate therapy for all post-op HTx 
patients. Similarly, Dall et al1 had a small cohort size of 16 and could have had similar risk of 
biases present.   
      The study produced by Dall et al12 showed that there was no difference in endothelial 
function between HIIT and CME. However, the author and colleagues stated that the test they 
used to measure endothelial function, the EndoPAT 2000, is not as sensitive as a test that was 
used in a prior study.12 The study that used the more sensitive FMD test found that patients that 
had done HIIT had significantly better FMD results when compared to a group that did only 
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CME.12 This study was not included in this analysis as it was published over 5 years ago. 
Additionally, Dall et al1 looked at many primary outcomes and so did not use the best test to 
evaluate endothelial function. This study12 discusses the limitations of the EndoPAT 2000 test in 
their report stating that FMD testing is a better test for evaluating the health of endothelium. This 
may be a source of inconsistency or indirectness in the data. 
 Using the information gathered from these two studies12,13 clinicians can consider HIIT a 
viable therapy for post-op heart transplant patients with a few considerations. First the patient 
needs to be stable enough to tolerate the therapy. Another consideration is that medication and 
lifestyle changes should also still be implemented and it is unlikely that HIIT or any other 
exercise training is going to prevent the development of CAV as a monotherapy. 
Moving forward clinicians should investigate to see if new evidence continues to suggest HIIT as 
a viable exercise regimen for stable post heart-transplant patients.  
CONCLUSION 
 
 High intensity interval training is a viable therapy to slow the progression of CAV when 
added to a stable post heart-transplant patient’s treatment plan. HIIT has been shown to be better 
at slowing the progression of CAV when compared to patients receiving no structured exercise 
therapy and it has been shown to be equivalent to continued moderate exercise. Since CAV is a 
widespread disease seen in post heart transplant patients and has high mortality and morbidity it 
is important to consider all potential options while treating these patients. While medication 
therapy with anti-proliferative drugs and statins early post-transplant is still the mainstay of 
treatment, the addition of an exercise regimen has been shown to be a viable addition to 
medication therapy. Further testing still needs to be done to evaluate if HIIT is an equivalent, 
better, or worse treatment method than CME in slowing the progression of CAV. 
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Table 1: 
 
Table 1: Quality Assessment of Reviewed Articles 
Study Design 
Downgrade Criteria 
Quality 
Limitations Indirectness Inconsistency Imprecision 
Publication 
bias 
Nytrøen 
et  al2 
RCT Not 
Serious 
Not Serious Not Serious Not Serious Unlikely High 
Dall et al1 RCT Not 
Serious 
Seriousa Not Serious Seriousb Unlikely Low 
a. The device used to measure endothelial function was inadequate at measuring the outcome. 
b. Small sample size 
 
